Please assess the completion status of the following clinical trial:

Trial Title: Propofol Cardioprotection for Type II Diabetics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with and without Type II Diabetes Mellitus~2. Hemodynamically Stable~3. Non urgent Coronary Bypass Grafting utilizing Cardiopulmonary Bypass~Exclusion Criteria:~1. Age less than 18 or greater than 80 years of age~2. refuse informed consent~3. Co-existing valvular heart disease~4. Acute or evolving myocardial infarction~5. hypersensitivity to propofol or formulation component~6. Use of NSAIDs, Vitamins C or E within 5 to 7 days of surgery

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 29 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Propofol Cardioprotection
- 2 (Type: EXPERIMENTAL): Volatile Anesthesia Preconditioning

Based on this trial design, predict the completion outcome and termination type (if applicable).